Fluoxetine in Tourette Syndrome
Abstract
An open label trial of fluoxetine (20-40 mg/d) was conducted in 32 Tourette syndrome patients with obsessive-compulsive disorder at the Department of Neurology, University of Rochester School of Medicine, NY.
DOI: https://doi.org/10.15844/pedneurbriefs-5-7-11 | Journal eISSN: 2166-6482
Language: English
Page range: 56 - 56
Published on: Jul 1, 1991
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1991 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.